Annals of Diagnostic Pathology
Volume 11, Issue 1 , Pages 3-9 , February 2007

Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas

References 

  1. Campman SC, Fajardo MA, Rippon MB, et al. Adenosquamous carcinoma arising in a mucinous cystadenoma of the pancreas. J Surg Oncol. 1997;64:159–162
  2. Kardon DE, Thompson LD, Przygodzki RM, et al. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Mod Pathol. 2001;14:443–451
  3. Inoue T, Nagao S, Tajima H, et al. Adenosquamous pancreatic cancer producing parathyroid hormone–related protein. J Gastroenterol. 2004;39:176–180
  4. Itani KM, Karni A, Green L. Squamous cell carcinoma of the pancreas. J Gastrointest Surg. 1999;3:512–515
  5. Kuroda N, Sawada T, Miyazaki E, et al. Anaplastic carcinoma of the pancreas with rhabdoid features. Pathol Int. 2000;50:57–62
  6. Paal E, Thompson LD, Frommelt RA, et al. A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. Ann Diagn Pathol. 2001;5:129–140
  7. Tschang T, Garza-Garza R, Kissane JM. Pleomorphic carcinoma of the pancreas. An analysis of 15 cases. Cancer. 1977;39:2114–2126
  8. Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical and clinical features of medullary carcinomas of the pancreas: a newly described and characterized entity. Am J Pathol. 2000;156:1641–1651
  9. Ray S, Lu Z, Rajendiran S. Clear cell ductal adenocarcinoma of pancreas: a case report and review of the literature. Arch Pathol Lab Med. 2004;128:693–696
  10. Molberg KH, Heffess CS, Delgado R, et al. Undifferentiated carcinomas with osteoclast-like giant cells of the pancreas and periampullary region. Cancer. 1998;82:1279–1287
  11. Watanabe M, Miura H, Inoue H, et al. Mixed osteoclastic/pleomorphic-type giant cell tumor of the pancreas with ductal adenocarcinoma: histochemical and immunohistochemical study with review of the literature. Pancreas. 1997;15:201–208
  12. Adsay NV, Logani S, Sarker F, et al. Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant. Am J Surg Pathol. 2000;24:493–504
  13. Tracey KJ, O'Brien MJ, Williams LF, et al. Signet ring carcinomas of the pancreas, a rare variant with very high CEA values. Immunohistologic comparison with adenocarcinoma. Dig Dis Sci. 1984;29:573–576
  14. Luttges J, Beyser K, Pust S, et al. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable. Mod Pathol. 2003;16:537–542
  15. Seidel G, Zahurak M, Iacobuzio-Donahue CA, et al. Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases. Am J Surg Pathol. 2002;26:56–63
  16. Hughes K, Kelty S, Martin R. Hepatoid carcinoma of the pancreas. Am Surg. 2004;70:1030–1033
  17. Paner GP, Thompson KS, Reyes CV. Hepatoid carcinoma of the pancreas. Cancer. 2000;88:1582–1589
  18. Yano T, Ishikura H, Wada T, et al. Hepatoid adenocarcinoma of the pancreas. Histopathology. 1999;35:90–92
  19. Albores-Saavedra J, Angeles-Angeles A, Nadji M, et al. Mucinous cystadenocarcinoma of the pancreas. Morphologic and immunocytochemical observations. Am J Surg Pathol. 1987;11–20
  20. Albores-Saavedra J, Gould EW, Angeles-Angeles A, et al. Cystic tumors of the pancreas. Pathol Annu. 1990;25:19–50
  21. Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. Atlas of tumor pathology. Washington (DC): AFIP [In press] [Fourth Series].
  22. Kloppel G, Hruban RH, Longnecker DS, et al. Ductal adenocarcinoma of the pancreas. In:  Hamilton SR,  Aaltonen LA editor. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000;p. 221–230
  23. Furukawa T, Kloppel G, Adsay V, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–799
  24. Albores-Saavedra J, Henson DE, Klimstra D. Tumors of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Atlas of tumor pathology. Washington (DC): AFIP; 2000;[Fascicle 27. Third series]
  25. Albores-Saavedra J, Nadji M, Henson DE, et al. Enteroendocrine cell differentiation in carcinomas of the gallbladder and mucinous cystadenocarcinomas of the pancreas. Pathol Res Pract. 1988;183:169
  26. Wang HL, Lu DW, Yuian LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;25:1380–1387
  27. Jaworski RC. Endocervical gland dysplasia, adenocarcinoma in situ and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol. 1990;7:190–204
  28. Inamura K, Satoh Y, Okumura S, et al. Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characters compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg Pathol. 2005;29:660–665
  29. Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 1986;10:192–202
  30. Cathro HP, Mills SE. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas. An immunohistochemical study of 22 cases utilizing CDX2 and MUC2. Am J Surg Pathol. 2004;28:1026–1032
  31. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. Atlas of tumor pathology. Washington (DC): AFIP; 1998;[Fascicle 23]
  32. Vang R, Gown AM, Barry TS, et al. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int J Gynecol Pathol. 2006;25:83–89
  33. Solcia E, Capella C, Kloppel G. Tumors of the pancreas. Atlas of tumor pathology. Washington (DC): Armed Forces Institute of Pathology; 1997;[Fascicle 20. Third Series]
  34. Albores-Saavedra J, Wu J, Crook T, et al. Intestinal and oncocytic variants of pancreatic intraepithelial neoplasia. A morphological and immunohistochemical study. Ann Diagn Pathol. 2005;9:69–76
  35. Albarracin CT, Jafri J, Montag AG, et al. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol. 2000;31:672–677
  36. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303–310
  37. Kaimaktchiev V, Terracciano L, Tornillo L, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol. 2004;17:1392–1399
  38. Lindsey B, Morrison C, Suster S, et al. CDX2 is a useful marker of intestinal-type differentiation. Arch Pathol Lab Med. 2005;129:1100–1105

PII: S1092-9134(06)00080-3

doi: 10.1016/j.anndiagpath.2006.06.008

Annals of Diagnostic Pathology
Volume 11, Issue 1 , Pages 3-9 , February 2007